CompoAtlas

Para-Lime

Food supplement declared in France, decision dated 23 October 2026

Para-Lime is a food supplement declared in France. Status: declared in France, may be marketed. 2 points in its composition require a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
WAYBIO LABORATOIRE
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
15 ml
Directions for use
15 ml par jour, à prendre pur ou dilué dans un grand verre d'eau tiède ou froide.
Intended populations
General population
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Allergy to salicylate derivatives, Pregnant women, Taking anticoagulants, Taking medication
Objectives stated by the manufacturer (these are not authorised claims)
Detox / Drainage

Declaration 380089, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Origanum vulgare L.Parties aériennesExtrait sec hydroalcoolique880 mg
Thymus vulgaris L.FeuilleExtrait sec hydroalcoolique330 mg
Allium sativum L.BulbeExtrait sec hydroalcoolique220 mg
Uncaria tomentosa (Willd. ex Schult.) DC.EcorceExtrait sec aqueux110 mg
Scutellaria baicalensis GeorgiRacineExtrait sec hydroalcoolique50.5 mg
Syzygium aromaticum (L.) Merr. & L.M.PerryBouton floralExtrait sec hydroalcoolique50 mg

Other active ingredients

NamePer day
mielnot declared

Micro-organisms

StrainPer day
Saccharomyces Cerevisiae Saccharomyces cerevisiae65,000,000,000 (unit not declared)

Additives

E300

Other ingredients

sirop de fructose

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Réservé aux adultes. Ne pas utiliser en cas de grossesse. Déconseillé en cas de traitement concomitant par un médicament anti-rétroviral (saquinavir, ritonavir,…) ou chez les personnes sous traitement anticoagulant. Déconseillé aux femmes allaitantes ou en cas d'allergie croisée connue en particulier à la famille des Lamiacées.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Thymus vulgaris L.
    Read the warning, when it applies and the studies cited

    THYME - THYMUS VULGARIS - Buccal

    Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Health Canada monograph dated 28 March 2025

    THYME - THYMUS VULGARIS - Oral

    Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.

    Health Canada monograph dated 26 June 2026

    THYME - THYMUS VULGARIS - Topical

    Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindications

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Health Canada monograph dated 28 February 2025

  • Allium sativum L.
    Read the warning, when it applies and the studies cited

    Garlic - Allium sativum

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All uses.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line